Electronic cigarettes: a survey of users

Etter, Jean-François
January 2010
BMC Public Health;2010, Vol. 10 Issue 1, p231
Academic Journal
Background: Little is known about users of electronic cigarettes, or their opinions, satisfaction or how and why they use such products. Methods: An internet survey of 81 ever-users of ecigarettes in 2009. Participants answered open-ended questions on use of, and opinions about, ecigarettes. Results: Respondents (73 current and 8 former users) lived in France, Canada, Belgium or Switzerland. Most respondents (77%) were men; 63% were former smokers and 37% were current smokers. They had used e-cigarettes for 100 days (median) and drew 175 puffs per day (median). Participants used the ecigarette either to quit smoking (53 comments), to reduce their cigarette consumption (14 comments), in order not to disturb other people with smoke (20 comments), or in smoke-free places (21 comments). Positive effects reported with ecigarettes included their usefulness to quit smoking, and the benefits of abstinence from smoking (less coughing, improved breathing, better physical fitness). Respondents also enjoyed the flavour of ecigarettes and the sensation of inhalation. Side effects included dryness of the mouth and throat. Respondents complained about the frequent technical failures of ecigarettes and had some concerns about the possible toxicity of the devices and about their future legal status. Conclusions: Ecigarettes were used mainly to quit smoking, and may be helpful for this purpose, but several respondents were concerned about potential toxicity. There are very few published studies on ecigarettes and research is urgently required, particularly on the efficacy and toxicity of these devices.


Related Articles

  • Out of the Ashes: The Life, Death, and Rebirth of the "Safer" Cigarette in the United States. Fairchild, Amy; Colgrove, James // American Journal of Public Health;Feb2004, Vol. 94 Issue 2, p192 

    From 1964 through the early 1980s, both federal and voluntary agencies endorsed the concept of "safer" cigarettes. Beginning in the mid-1980s, several factors, including revelations of tobacco industry malfeasance, the development of nicotine replacement therapy, and the reconceptualization of...

  • Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study.  // British Dental Journal;7/11/2014, Vol. 217 Issue 1, p31 

    'I am still not smoking'; e-cigarettes were more effective than nicotine replacement therapy (NRT) or no aid.

  • Union calls for immediate regulation of e-cigarette products.  // Hem/Onc Today;1/25/2014, Vol. 15 Issue 2, p9 

    The article reports on the International Union Against Tuberculosis and Lung Health's call for urgent regulation of electronic cigarettes (e-cigarettes) and electronic nicotine delivery systems due to concerns about safety and chemical content.

  • E-cigarettes: Facts and legal status. Sinniah, Davendralingam; Khoo, Erwin Jiayuan // International E-Journal of Science, Medicine & Education;Nov2015, Vol. 9 Issue 3, p10 

    The sale of tobacco-based cigarettes has declined in western countries, and 'Big Tobacco' is trying to make up the deficit in profits from the developing world. The recent introduction of e-cigarette, in which they have invested both their hopes and their finances, has been a boon to them as it...

  • Targeting smokers at increased risk for relapse: treating women and those with a history of depression. Smith, Stevens S.; Jorenby, Douglas E.; Leischow, Scott J.; Nides, Mitchell A.; Rennard, Stephen I.; Johnston, J. Andrew; Jamerson, Brenda; Fiore, Michael C.; Baker, Timothy B. // Nicotine & Tobacco Research;Feb2003, Vol. 5 Issue 1, p99 

    Some studies have shown that female smokers and smokers with a history of depression have an increased risk of relapse following smoking cessation treatment. This study examined the efficacy of bupropion sustained-release (SR) and the nicotine patch for smoking cessation in subgroups of smokers...

  • Use of Sustained-Release Bupropion in Specific Patient Populations for Smoking Cessation. Tonstad, S. // Drugs;2002 Supplement 2, Vol. 62 Issue 11, p37 

    Smoking cessation trials of sustained-release bupropion (bupropion SR) were initially conducted in a general population of smokers who were motivated to quit smoking. Bupropion SR has also been found to be a useful treatment of tobacco dependence in various special populations of smokers who...

  • Clinical Efficacy of Bupropion in the Management of Smoking Cessation. Jorenby, D. // Drugs;2002 Supplement 2, Vol. 62 Issue 11, p25 

    Nicotine addiction is a chronic relapsing condition that can be difficult to treat. Until recently, pharmacological options for the treatment of tobacco dependence were primarily limited to nicotine replacement therapy (NRT). Sustained-release bupropion (bupropion SR) is the first non-nicotine...

  • Pharmacokinetic Optimisation of Sustained-Release Bupropion for Smoking Cessation. Johnston, A.J.; Ascher, J.; Leadbetter, R.; Schmith, V.D.; Patel, D.K.; Durcan, M.; Bentley, B. // Drugs;2002 Supplement 2, Vol. 62 Issue 11, p11 

    Sustained-release bupropion (bupropion SR) is a unique, non-nicotine smoking cessation aid that is hypothesised to act upon neurological pathways involved in nicotine dependence. Pharmacokinetic and metabolism studies reveal that bupropion SR is metabolised by multiple pathways with no single...

  • GP helps smokers choose how to quit.  // Pulse;11/24/2003, Vol. 63 Issue 47, p12 

    Reports on the development of a booklet by Doctor Richard Thomas to help smokers quit from smoking in Wales. Advantages and disadvantages of various options for smoking management; Existence of products for smoking cessation.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics